Methodological Approaches to Preclinical Evaluation of General Toxicity of Therapeutic Radiopharmaceuticals
Radiopharmaceuticals differ from other medicines mainly by the specific nature of their pharmacological action based on radioactivity, by absence of multiple-dose regimens, and by miniscule concentrations of the active pharmaceutical ingredient (10-9–10-12 mol/L). However, the official regulations a...
Saved in:
Main Authors: | O. E. Klementyeva, A. S. Lunev, C. A. Lunyova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2021-12-01
|
Series: | Регуляторные исследования и экспертиза лекарственных средств |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/379 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of Current Rules and Regulations for Preclinical Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2024-02-01) -
Pharmacokinetic Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2022-12-01) -
Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01) -
Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods
by: G. E. Kodina, et al.
Published: (2022-10-01) -
Regulation of Radiopharmaceutical Products
by: V. V. Kosenko, et al.
Published: (2022-12-01)